Megestrolazetat in verschiedenen Dosierungen bei der Behandlung des metastasierenden Mammakarzinoms — Klinische und endokrinologische Untersuchungen

@article{Wander2005MegestrolazetatIV,
  title={Megestrolazetat in verschiedenen Dosierungen bei der Behandlung des metastasierenden Mammakarzinoms — Klinische und endokrinologische Untersuchungen},
  author={H. -E. Wander and H. -Ch. Blossey and Gerd Arno Nagel and Dieter Emrich},
  journal={Klinische Wochenschrift},
  year={2005},
  volume={63},
  pages={312-318}
}
Both medroxyprogesterone acetate (MPA) and megestrol acetate (MA) are effective in the treatment of metastatic breast cancer. Although the dose-dependent mode of actions of MPA have been extensively clarified, there is still some uncertainty regarding the mode of actions and dosage of MA. Thirty-three patients with metastatic breast cancer were treated with… CONTINUE READING